Login

ClearVue Technologies Ltd CEO Basil Karampelas discusses his new role as North American leader in an interview with Proactive. 00:10:00

Share On Facebook Share On Twitter

Chuck Mowrey. CEO and President North America

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Advancing Neoantigen-Targeted Therapies with Jenosha's Atlas Platform
00:10:00
Embracing Giving, Acknowledging Uncertainty, and Riding the Entrepreneurial Rollercoaster |José E. Feliciano, Co-Founder, Clearlake Capital Group.
00:10:00
Market Insights, IRS Strategies, and 529 Plan Essentials with Michael McCarthy | Michael McCarthy, President, Financial Consulate Inc.
00:10:00
Expanding Horizons: Amy Lo on Asia’s Wealth Management Potential | Amy Lo – Chairman, Global Wealth Management Asia, UBS
00:10:00
Advancing Risk-Informed Decision Making in Tailings Management
00:10:00
Resolving Cross-Border Transfer Pricing Disputes: Insights from Clark Armitage on the 'GILTI Conscience' Podcast | John Slate - Founder of Skadden
00:10:00
4 Strategies to Help Your Loved Ones Achieve Financial Success | McKenna Clifford - Wealth Manager at Credent Wealth Management
00:10:00
Embracing the Circular Economy and Renewable Energy: A Vision for 2050 | Renato Mazzoncini , CEO, A2A Spa.
00:10:00
Exploring New Frontiers: Canex Metals' Promising Gold Discoveries in Northern Arizona
00:10:00
Solvency II Back to Basics: Understanding Technical Provisions | John Slate - Founder of Skadden
00:10:00
Will Creedon of John Hancock Investment Management discusses the implications of unprecedented market volatility.
00:10:00
Defense Tech Leader: Cohort (AIM: CHRT) | Andrew Thomis - CEO of cohort plc

© 2017 - Neuhu+